{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:06:51Z","timestamp":1784549211620,"version":"3.55.0"},"reference-count":49,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Acute-on-chronic liver failure (ACLF) affects approximately one-third of patients hospitalized for acute decompensation of cirrhosis. These patients exhibit an extremely high degree of systemic inflammation, and infections as well as severe alcohol-related hepatitis are the most common precipitating factors of ACLF.  Objective: This paper aims to discuss the most relevant aspects of ACLF emphasizing the role of gut dysbiosis.  Methods: This review includes clinical and epidemiological studies, meta-analyses, and other articles published in English and indexed in the following databases: PubMed, Scopus, and Embase. Only full-text articles were selected.  Results: ACLF is the most severe complication in patients with cirrhosis and is associated with high mortality rates. Bacterial translocation is considered responsible for the systemic inflammation leading to acute decompensation of cirrhosis when other precipitating events are not identified. Different microbiome profiles may influence the incidence of decompensation and thus the clinical course of the disease. Dysbiosis causes intestinal inflammation, which contributes to gut barrier dysfunction and pathological bacterial translocation, the main triggering factor of the cascade leading to acute decompensation of cirrhosis and multiple organ failure. Since dysbiosis plays a central role in the pathophysiology of acute decompensation of cirrhosis and ACLF, it is expected that treatments targeting the microbiome could modify the course of the disease. Despite current limitations, the role of probiotics, prebiotics, postbiotics, rifaximin, bacteriophages, and fecal microbiota transplantation is discussed in the present review.  Conclusion: ACLF is a highly significant complication of liver disease. Dysbiosis and the gut-liver axis play key roles in its pathophysiology. This knowledge supports the idea that manipulation of the microbiome may be a potential therapeutic strategy.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612025-141","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:30:31Z","timestamp":1784547031000},"source":"Crossref","is-referenced-by-count":0,"title":["DYSBIOSIS IN ACUTE-ON-CHRONIC LIVER FAILURE - FROM A PATHOPHYSIOLOGICAL COMPONENT TO A THERAPEUTIC TARGET"],"prefix":"10.1590","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2417-9765","authenticated-orcid":false,"given":"Angelo A.","family":"MATTOS","sequence":"first","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre,  Brasil; Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1070-9747","authenticated-orcid":false,"given":"Cristiane A.","family":"ALVES","sequence":"additional","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-883X","authenticated-orcid":false,"given":"Johana","family":"ACU\u00d1A","sequence":"additional","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3063-0199","authenticated-orcid":false,"given":"Angelo Z.","family":"MATTOS","sequence":"additional","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre,  Brasil; Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis","volume":"144","author":"Moreau R","year":"2013","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.aohep.2019.01.001","article-title":"Acute-on-chronic liver failure: A comparison of three different diagnostic criteria","volume":"18","author":"Le\u00e3o GS","year":"2019","journal-title":"Ann Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/gutjnl-2020-322161","article-title":"Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis","volume":"71","author":"Mezzano G","year":"2022","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"696716","DOI":"10.1053\/j.gastro.2023.05.033","article-title":"Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America","volume":"165","author":"Farias AQ","year":"2023","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cgh.2018.08.008","article-title":"Altered Microbiome in Patients With Cirrhosis and Complications","volume":"17","author":"Acharya C","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab JP","year":"2018","journal-title":"Hepatol Int"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.14309\/ajg.0000000000002581","article-title":"The Current and Future State of Microbiome Therapeutics in Liver Disease","volume":"119","author":"Bloom PP","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi M","year":"2015","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17474124.2018.1481747","article-title":"Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications","volume":"12","author":"Ponziani FR","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/HEP.0000000000000344","article-title":"Gut microbiome-brain-cirrhosis axis","volume":"80","author":"Smith ML","year":"2024","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","article-title":"The microbiota in cirrhosis and its role in hepatic decompensation","volume":"75","author":"Trebicka J","year":"2021","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka J","year":"2020","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2020.11.019","article-title":"PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis","volume":"74","author":"Trebicka J","year":"2021","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"052","DOI":"10.1055\/a-2516-2361","article-title":"Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure","volume":"45","author":"Pohl J","year":"2025","journal-title":"Semin Liver Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/gutjnl-2024-333876","article-title":"Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis","volume":"74","author":"Trebicka J","year":"2025","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41575-018-0045-2","article-title":"Novel perspectives in the management of decompensated cirrhosis","volume":"15","author":"Bernardi M","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo V","year":"2021","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","article-title":"Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure","volume":"74","author":"Wong F","year":"2021","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide","volume":"156","author":"Piano S","year":"2019","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"01","DOI":"10.35946\/arcr.v44.1.01","article-title":"Gut-Liver-Brain Axis and Alcohol Use Disorder: Treatment Potential of Fecal Microbiota Transplantation","volume":"44","author":"Wolstenholme J","year":"2024","journal-title":"Alcohol Res Curr Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis","volume":"133","author":"Fern\u00e1ndez J","year":"2007","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jhep.2008.01.024","article-title":"Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled study","volume":"48","author":"Terg R","year":"2008","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins SW","year":"2021","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi M","year":"2024","journal-title":"The Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/j.gastro.2021.05.043","article-title":"Meeting the Challenge of Antimicrobial Resistance in Cirrhosis: The Invisible Threat That Lies Within","volume":"161","author":"Edwards LA","year":"2021","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jhep.2021.12.042","article-title":"Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis","volume":"76","author":"Prado V","year":"2022","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2021.04.013","article-title":"Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis","volume":"161","author":"Shamsaddini A","year":"2021","journal-title":"Gastroenterology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"20140087","DOI":"10.1098\/rstb.2014.0087","article-title":"The human gut resistome","volume":"370","author":"Van Schaik W","year":"2015","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1097\/HEP.0000000000000184","article-title":"Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration","volume":"77","author":"Badal BD","year":"2023","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.14309\/ajg.0000000000003075","article-title":"Higher Rate of Spontaneous Bacterial Peritonitis Recurrence With Secondary Spontaneous Bacterial Peritonitis Prophylaxis Compared With No Prophylaxis in 2 National Cirrhosis Cohorts","volume":"120","author":"Silvey S","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.08.026","article-title":"Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis","volume":"155","author":"Moreau R","year":"2018","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032335","article-title":"Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis","volume":"101","author":"Huang L","year":"2022","journal-title":"Medicine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2021.12.003","article-title":"Promises of microbiome-based therapies","volume":"76","author":"Bajaj JS","year":"2022","journal-title":"J Hepatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin Treatment in Hepatic Encephalopathy","volume":"362","author":"Bass NM","year":"2010","journal-title":"N Engl J Med"},{"key":"ref35","first-page":"S0168827825023189","article-title":"Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial","author":"Th\u00e9venot T","year":"2025","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1742-1241.2011.02650.x","article-title":"Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - a systematic review and meta-analysis: PPI and risk of SBP - a meta-analysis","volume":"65","author":"Trikudanathan G","year":"2011","journal-title":"Int J Clin Pract"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/hep.28737","article-title":"Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites","volume":"64","author":"Dam G","year":"2016","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/hep.29132","article-title":"Risks of proton pump inhibitors for patients with cirrhosis: The controversy remains","volume":"66","author":"De Mattos \u00c2Z","year":"2017","journal-title":"Hepatology"},{"key":"ref39","article-title":"Therapeutic manipulation of the microbiome in liver disease","author":"Parthasarathy G","year":"2024","journal-title":"Hepatology"},{"key":"ref40","first-page":"854","article-title":"Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis","volume":"44","author":"Eiseman B","year":"1958","journal-title":"Surgery"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile","volume":"368","author":"Van Nood E","year":"2013","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.30037","article-title":"Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant","volume":"68","author":"Bajaj JS","year":"2018","journal-title":"Hepatology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hep4.1639","article-title":"Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials","volume":"5","author":"Bajaj JS","year":"2021","journal-title":"Hepatol Commun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhin.2019.03.010","article-title":"Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis","volume":"102","author":"Tavoukjian V","year":"2019","journal-title":"J Hosp Infect"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.31496","article-title":"A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder","volume":"73","author":"Bajaj JS","year":"2021","journal-title":"Hepatology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jceh.2022.01.001","article-title":"Long-term Outcomes of Stool Transplant in Alcohol-associated Hepatitis-Analysis of Clinical Outcomes, Relapse, Gut Microbiota and Comparisons with Standard Care","volume":"12","author":"Philips CA","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12072-022-10438-0","article-title":"Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial","volume":"17","author":"Pande A","year":"2023","journal-title":"Hepatol Int"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12072-022-10312-z","article-title":"Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial","volume":"16","author":"Sharma A","year":"2022","journal-title":"Hepatol Int"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/antibiotics11070838","article-title":"Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy","volume":"11","author":"Hong AS","year":"2022","journal-title":"Antibiotics"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Disbiose na fal\u00eancia hep\u00e1tica cr\u00f4nica agudizada: de componente fisiopatol\u00f3gico a alvo terap\u00eautico"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032026000105006&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:30:38Z","timestamp":1784547038000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032026000105006&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":49,"alternative-id":["S0004-28032026000105006"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612025-141","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e25141"}}